$35.17
1.90% day before yesterday
Nasdaq, Jul 18, 10:00 pm CET
ISIN
US90184D1000
Symbol
TWST
Sector
Industry

Twist Bioscience Corp. Stock price

$35.17
-0.72 2.01% 1M
-12.39 26.05% 6M
-11.30 24.32% YTD
-18.39 34.34% 1Y
-5.23 12.95% 3Y
-21.17 37.58% 5Y
+21.17 151.21% 10Y
+21.17 151.21% 20Y
Nasdaq, Closing price Fri, Jul 18 2025
-0.68 1.90%
ISIN
US90184D1000
Symbol
TWST
Sector
Industry

Key metrics

Basic
Market capitalization
$2.1b
Enterprise Value
$1.9b
Net debt
positive
Cash
$257.2m
Shares outstanding
59.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
6.1 | 5.5
EV/Sales
5.3 | 4.8
EV/FCF
negative
P/B
4.8
Financial Health
Equity Ratio
76.9%
Return on Equity
-44.2%
ROCE
-38.6%
ROIC
-62.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$347.7m | $384.2m
EBITDA
$-173.4m | $-86.2m
EBIT
$-201.2m | $-142.6m
Net Income
$-191.2m | $-132.8m
Free Cash Flow
$-65.5m
Growth (TTM | estimate)
Revenue
25.3% | 22.8%
EBITDA
-0.1% | 40.3%
EBIT
2.7% | 18.9%
Net Income
0.5% | 36.4%
Free Cash Flow
31.4%
Margin (TTM | estimate)
Gross
46.7%
EBITDA
-49.9% | -22.4%
EBIT
-57.9%
Net
-55.0% | -34.6%
Free Cash Flow
-18.8%
More
EPS
$-3.2
FCF per Share
$-1.1
Short interest
19.4%
Employees
923
Rev per Employee
$340.0k
Show more

Is Twist Bioscience Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Twist Bioscience Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Twist Bioscience Corp. forecast:

14x Buy
78%
3x Hold
17%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a Twist Bioscience Corp. forecast:

Buy
78%
Hold
17%
Sell
6%

Financial data from Twist Bioscience Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
348 348
25% 25%
100%
- Direct Costs 185 185
8% 8%
53%
162 162
53% 53%
47%
- Selling and Administrative Expenses 230 230
14% 14%
66%
- Research and Development Expense 89 89
7% 7%
26%
-173 -173
0% 0%
-50%
- Depreciation and Amortization 28 28
17% 17%
8%
EBIT (Operating Income) EBIT -201 -201
3% 3%
-58%
Net Profit -191 -191
1% 1%
-55%

In millions USD.

Don't miss a Thing! We will send you all news about Twist Bioscience Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Twist Bioscience Corp. Stock News

Positive
Seeking Alpha
5 days ago
Twist Bioscience continues to grow revenue at a healthy pace, posting 23% year-over-year sales growth and beating EPS expectations in its most recent quarter. The company holds $255 million in cash and no long-term debt. Management also just announced a spin-off that should reduce operating expenses and cash burn rate. With the stock down more than 10% since the last time Twist Bioscience was p...
Neutral
Business Wire
6 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 third quarter ended June 30, 2025, before the opening of the market on August 4, 2025. The company plans to hold a conference ...
Neutral
Business Wire
13 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today accelerated its Express turnaround time for all Twist Gene Fragments with a turnaround time starting at two business days for both adapters off and adaptors on configurations. “We continue to itera...
More Twist Bioscience Corp. News

Company Profile

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.

Head office United States
CEO Emily Leproust
Employees 923
Founded 2013
Website www.twistbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today